125 related articles for article (PubMed ID: 24610936)
1. Surfactant protein D is a candidate biomarker for subclinical tobacco smoke-induced lung damage.
Johansson SL; Tan Q; Holst R; Christiansen L; Hansen NC; Hojland AT; Wulf-Johansson H; Schlosser A; Titlestad IL; Vestbo J; Holmskov U; Kyvik KO; Sorensen GL
Am J Physiol Lung Cell Mol Physiol; 2014 May; 306(9):L887-95. PubMed ID: 24610936
[TBL] [Abstract][Full Text] [Related]
2. Association between the surfactant protein D (SFTPD) gene and subclinical carotid artery atherosclerosis.
Sorensen GL; Bladbjerg EM; Steffensen R; Tan Q; Madsen J; Drivsholm T; Holmskov U
Atherosclerosis; 2016 Mar; 246():7-12. PubMed ID: 26748346
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of surfactant protein D rs2243639, Interleukin (IL)-1β rs16944 and IL-1RN rs2234663 in chronic obstructive pulmonary disease, healthy smokers, and non-smokers.
Issac MS; Ashur W; Mousa H
Mol Diagn Ther; 2014 Jun; 18(3):343-54. PubMed ID: 24504887
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants of pulmonary SP-D predict disease outcome of COPD in a Chinese population.
Ou CY; Chen CZ; Hsiue TR; Lin SH; Wang JY
Respirology; 2015 Feb; 20(2):296-303. PubMed ID: 25376584
[TBL] [Abstract][Full Text] [Related]
5. Increased serum SP-D in identification of high-risk smokers at high risk of COPD.
Dalgård C; Wang F; Titlestad IL; Kyvik KO; Vestbo J; Sorensen GL
Am J Physiol Lung Cell Mol Physiol; 2021 Jun; 320(6):L1005-L1010. PubMed ID: 33759571
[TBL] [Abstract][Full Text] [Related]
6. SNP rs3088308 is a risk factor for poor lung function in healthy smokers.
Shakoori TA; Sin DD
J Pak Med Assoc; 2016 Sep; 66(9):1137-1141. PubMed ID: 27654735
[TBL] [Abstract][Full Text] [Related]
7. Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking.
Kobayashi H; Kanoh S; Motoyoshi K
Biomarkers; 2008 Jun; 13(4):385-92. PubMed ID: 18595202
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the human surfactant protein-D (SFTPD) gene: strong evidence that serum levels of surfactant protein-D (SP-D) are genetically influenced.
Heidinger K; König IR; Bohnert A; Kleinsteiber A; Hilgendorff A; Gortner L; Ziegler A; Chakraborty T; Bein G
Immunogenetics; 2005 Apr; 57(1-2):1-7. PubMed ID: 15700120
[TBL] [Abstract][Full Text] [Related]
9. Surfactant protein D as a marker for pulmonary complications in pediatric patients with sickle cell disease: Relation to lung function tests.
Tantawy AA; Adly AA; Ebeid FSE; Ismail EA; Hussein MM; Shaarawy RM; Kamel RA
Pediatr Pulmonol; 2019 May; 54(5):610-619. PubMed ID: 30672154
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease.
Foreman MG; Kong X; DeMeo DL; Pillai SG; Hersh CP; Bakke P; Gulsvik A; Lomas DA; Litonjua AA; Shapiro SD; Tal-Singer R; Silverman EK
Am J Respir Cell Mol Biol; 2011 Mar; 44(3):316-22. PubMed ID: 20448057
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD.
Winkler C; Atochina-Vasserman EN; Holz O; Beers MF; Erpenbeck VJ; Krug N; Roepcke S; Lauer G; Elmlinger M; Hohlfeld JM
Respir Res; 2011 Mar; 12(1):29. PubMed ID: 21396106
[TBL] [Abstract][Full Text] [Related]
12. Surfactant protein-D-encoding gene variant polymorphisms are linked to respiratory outcome in premature infants.
Sorensen GL; Dahl M; Tan Q; Bendixen C; Holmskov U; Husby S
J Pediatr; 2014 Oct; 165(4):683-9. PubMed ID: 25015576
[TBL] [Abstract][Full Text] [Related]
13. Candidate gene analysis of the surfactant protein D gene in pediatric diffuse lung disease.
Gower WA; Nogee LM
J Pediatr; 2013 Dec; 163(6):1778-80. PubMed ID: 23932215
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects.
Robin M; Dong P; Hermans C; Bernard A; Bersten AD; Doyle IR
Eur Respir J; 2002 Nov; 20(5):1152-61. PubMed ID: 12449168
[TBL] [Abstract][Full Text] [Related]
15. Effect of GSTM2-5 polymorphisms in relation to tobacco smoke exposures on lung function growth: a birth cohort study.
Alexander M; Karmaus W; Holloway JW; Zhang H; Roberts G; Kurukulaaratchy RJ; Arshad SH; Ewart S
BMC Pulm Med; 2013 Sep; 13():56. PubMed ID: 24004509
[TBL] [Abstract][Full Text] [Related]
16. Influence of genetic variability at the surfactant proteins A and D in community-acquired pneumonia: a prospective, observational, genetic study.
García-Laorden MI; Rodríguez de Castro F; Solé-Violán J; Rajas O; Blanquer J; Borderías L; Aspa J; Briones ML; Saavedra P; Marcos-Ramos JA; González-Quevedo N; Sologuren I; Herrera-Ramos E; Ferrer JM; Rello J; Rodríguez-Gallego C
Crit Care; 2011; 15(1):R57. PubMed ID: 21310059
[TBL] [Abstract][Full Text] [Related]
17. Genes and pathways underlying susceptibility to impaired lung function in the context of environmental tobacco smoke exposure.
de Jong K; Vonk JM; Imboden M; Lahousse L; Hofman A; Brusselle GG; Probst-Hensch NM; Postma DS; Boezen HM
Respir Res; 2017 Jul; 18(1):142. PubMed ID: 28738859
[TBL] [Abstract][Full Text] [Related]
18. Association of serum surfactant protein D and SFTPD gene variants with asthma in Danish children, adolescents, and young adults.
Hoffmann-Petersen B; Suffolk R; Petersen JJH; Petersen TH; Brasch-Andersen C; Høst A; Halken S; Sorensen GL; Agertoft L
Immun Inflamm Dis; 2022 Feb; 10(2):189-200. PubMed ID: 34780682
[TBL] [Abstract][Full Text] [Related]
19. The effect of habitual waterpipe tobacco smoking on pulmonary function and exercise capacity in young healthy males: A pilot study.
Hawari FI; Obeidat NA; Ghonimat IM; Ayub HS; Dawahreh SS
Respir Med; 2017 Jan; 122():71-75. PubMed ID: 27993294
[TBL] [Abstract][Full Text] [Related]
20. Serum-surfactant SP-D correlates inversely to lung function in cystic fibrosis.
Olesen HV; Holmskov U; Schiøtz PO; Sørensen GL
J Cyst Fibros; 2010 Jul; 9(4):257-62. PubMed ID: 20457545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
